Transcranial Temporal Interference Stimulation (tTIS) To Modulate Essential Tremor
NCT: NCT07531238 · NOT_YET_RECRUITING
Brief Summary
The goal of this proof-of-concept study is to examine the effects of a relatively new, non-invasive electrical current-based technique, transcranial temporal interference stimulation (tTIS), in patients with Essential Tremor (ET). TTIS is delivered via a Digitimer Ltd. stimulator, the "DS5 Isolated Bipolar Constant Current Stimulator." The method enables targeting deep cerebral structures to selectively modulate neurons. The structure of interest in the present study is the ventralis intermedius (VIM) of the thalamus, which plays a key role in tremor generation in people with essential tremor. Therefore, techniques targeting the VIM nucleus can potentially improve the tremor and the quality of life in the long term, as is the case with MRI-guided high-intensity focused ultrasound (MRgHIFU). Despite its efficiency, MRgHIFU can lead to side effects that could benefit from improved predictive modeling. In our proof-of-concept study, the investigators aim to examine whether tTIS of the VIM nucleus can alter tremor characteristics and, therefore, mimic the effects of MRgHIFU. This work would pave the way for future clinical trials to design prediction tools for MRgHIFU if the investigators can demonstrate the positive impact of tTIS.
Frequently Asked Questions
What is Transcranial Temporal Interference Stimulation (tTIS) To Modulate Essential Tremor?
Transcranial Temporal Interference Stimulation (tTIS) To Modulate Essential Tremor is a clinical trial registered under NCT07531238. Current status: NOT_YET_RECRUITING.
What is the status of NCT07531238?
The current status of NCT07531238 (Transcranial Temporal Interference Stimulation (tTIS) To Modulate Essential Tremor) is: NOT_YET_RECRUITING.
When did Transcranial Temporal Interference Stimulation (tTIS) To Modulate Essential Tremor start?
Transcranial Temporal Interference Stimulation (tTIS) To Modulate Essential Tremor started on 2026-05-26.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.